For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Radius Health, Inc.

USPTO Granted Patents = 23

% Expired Patents = 4.3

EPO Patents = 11

Trademarks = 6

Forward Citations = 221

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Chris P Miller (7 out of 7 patents)

C Richard Lyttle (6 out of 9 patents)

Bart Henderson (5 out of 17 patents)

4. Greg Williams (4 out of 4 patents)

5. Naveen Palwai (4 out of 4 patents)

6. David Hanley (4 out of 4 patents)

7. Nathalie Mondoly (4 out of 8 patents)

8. Benedicte Rigaud (4 out of 4 patents)

9. Michael J Dey (4 out of 6 patents)

10. Gary Hattersley (3 out of 14 patents)

11. Heidi K Chandler (2 out of 2 patents)

12. Alan Harris (2 out of 3 patents)

13. Jamal Saeh (2 out of 4 patents)

14. Ehab Hamed (2 out of 2 patents)

15. Daniel Dohmeier (2 out of 3 patents)

23 patents: Sort by Forward Citations

1. 12496330 - METHODS OF IMPROVING SPINAL FUSION WITH ABALOPARATIDE (2025-12-16),

2. 11977067 - Abaloparatide formulations and methods of testing, storing, modifying, and using same (2024-05-07),

3. 11835506 - Abaloparatide formulations and methods of testing, storing, modifying, and using same (2023-12-05),

4. 11806387 - Process of making abaloparatide (2023-11-07),

5. 11782041 - Abaloparatide formulations and methods of testing, storing, modifying, and using same (2023-10-10),

6. 11680942 - Methods for detecting neutralizing antibodies to parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHrP) analog (2023-06-20),

7. RE49444 - Method of treating osteoporosis comprising administration of PTHrP analog (2023-03-06),

8. 11255842 - Methods for detecting neutralizing antibodies to parathyroid hormone (PTH) and parathyroid hormone-related peptide (PTHRP) analog (2022-02-22),

9. 10996208 - Abaloparatide formulations and methods of testing, storing, modifying, and using same (2021-05-04),

10. 10980862 - Formulations of abaloparatide, transdermal patches thereof, and uses thereof (2021-04-20),

11. 10568937 - Formulations of abaloparatide, transdermal patches thereof, and uses thereof (2020-02-25),

12. 9555014 - Therapeutic regimens (2017-01-31),

13. 9133182 - Selective androgen receptor modulators (2015-09-15),

14. 8987319 - Selective androgen receptor modulators (2015-03-24),

15. 8933130 - Treatment of vasomotor symptoms with selective estrogen receptor modulators (2015-01-13),

Company Overview

Radius Health, Inc. is a biopharmaceutical company based in Boston, MA, specializing in the development of innovative therapeutics for patients with osteoporosis and other serious endocrine diseases. The company focuses on advancing its pipeline of products through research and development, leveraging its expertise in bone health and metabolic disorders. Radius is committed to addressing unmet medical needs and improving patient outcomes through its targeted therapies and collaborative efforts in the healthcare sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

23 Patents

#102 in Boston, MA

#866 in Massachusetts

#14,415 in US

#27,649 in the World

Boston, MA, United States of America

Radius Health, Inc.

Forward Citations = 221

26 inventors:

Chris P Miller (7 out of 7 patents)

C Richard Lyttle (6 out of 9 patents)

Bart Henderson (5 out of 17 patents)

4. Greg Williams (4 out of 4 patents)

5. Naveen Palwai (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Radius Health, Inc.. Retrieved from https://idiyas.com/company/radius-health

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…